IMAGE: Lung squamous cell carcinoma

Breaking News

Key: Meeting M      Journal J      Funder F

Showing releases 226-250 out of 1377.

<< < 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 > >>

Public Release: 21-Jul-2016
Addiction
New review concludes that evidence for alcohol causing cancer is strong
A new review of epidemiological evidence supports a causal association between alcohol consumption and cancers at seven sites in the body: oropharynx, larynx, esophagus, liver, colon, rectum and female breast.

Contact: Jean O'Reilly
jean@addictionjournal.org
020-784-80853
Society for the Study of Addiction

Public Release: 21-Jul-2016
Cell Systems
Carnegie Mellon algorithm characterizes how cancer genomes get scrambled
A new method developed by Carnegie Mellon University for analyzing the scrambled genomes of cancer cells gives researchers for the first time the ability to simultaneously identify two different types of genetic changes associated with cancers and to identify connections between the two.
National Institutes of Health, National Science Foundation

Contact: Byron Spice
bspice@cs.cmu.edu
412-268-9068
Carnegie Mellon University

Public Release: 21-Jul-2016
Cell Reports
New therapeutic targets for small cell lung cancer identified
UT Southwestern Medical Center researchers have identified a protein termed ASCL1 that is essential to the development of small cell lung cancer and that, when deleted in the lungs of mice, prevents the cancer from forming.

Contact: Lori Sundeen Soderbergh
Lori.soderbergh@utsouthwestern.edu
214-648-3404
UT Southwestern Medical Center

Public Release: 21-Jul-2016
JCI Insight
Sorafenib treatment alters immunosuppressive phenotypes in hepatocellular carcinoma
In this issue of JCI Insight, Yasmin Thanavala and colleagues at Roswell Park Cancer Institute evaluated the immune response in a small cohort of patients with advanced hepatocellular carcinoma before and after treatment with sorafenib.
NIH/National Cancer Institute

Contact: Corinne Williams
press_releases@the-jci.org
JCI Journals

Public Release: 21-Jul-2016
JCI Insight
A new method for prostate cancer imaging
In this issue of JCI Insight, researchers at the University of British Columbia describe a new imaging tool to detect the presence of the androgen receptor and its active splice variants.
NIH/National Cancer Institute

Contact: Corinne Williams
press_releases@the-jci.org
JCI Journals

Public Release: 21-Jul-2016
JAMA Oncology
Are provider-related factors affecting the likelihood of breast preservation?
Do regional practice patterns for radiotherapy for ductal carcinoma in situ (DCIS) breast cancer increase the likelihood of mastectomy when there is a second breast cancer in women who did not receive radiotherapy at the initial DCIS diagnosis?

Contact: John Noble
JohnW_Noble@dfci.harvard.edu
617-632-4090
The JAMA Network Journals

Public Release: 21-Jul-2016
Science Advances
A more powerful way to develop therapeutics?
A University of Toronto scientist has developed a new method for identifying the raw ingredients necessary to build 'biologics,' a powerful class of medications that has revolutionized treatment of diseases like rheumatoid arthritis and some cancers.

Contact: Heidi Singer
Heidi.Singer@utoronto.ca
416-978-5811
University of Toronto

Public Release: 21-Jul-2016
Practical Radiation Oncology
New ASTRO clinical practice statement updates treatment standard for rectal cancer
The American Society for Radiation Oncology (ASTRO) recently issued a new clinical practice statement, 'Appropriate Customization of Radiation Therapy for Stage II and III Rectal Cancer: An ASTRO Clinical Practice Statement Using the RAND/UCLA Appropriateness Method.'

Contact: Liz Gardner
liz.gardner@astro.org
703-286-1600
American Society for Radiation Oncology

Public Release: 21-Jul-2016
Molecular Cell
Researchers ID cancer gene-drug combinations ripe for precision medicine
In an effort to expand the number of cancer gene mutations that can be specifically targeted with personalized therapies, researchers at University of California San Diego School of Medicine and Moores Cancer Center looked for combinations of mutated genes and drugs that together kill cancer cells. The study, published July 21 in Molecular Cell, uncovered 172 new combinations that could form the basis for future cancer therapies.
National Institutes of Health, Damon Runyon Cancer Research Foundation, Marsha Rivkin Center for Ovarian Cancer Research, Conquer Cancer Foundation of ASCO Young Investigator Award, European Research Council

Contact: Heather Buschman
hbuschman@ucsd.edu
858-249-0456
University of California - San Diego

Public Release: 20-Jul-2016
Journal of Investigative Dermatology
New sun cream compound offers unprecedented protection against UVA radiation
A new wonder compound developed by University of Bath scientists in collaboration with King's College London offers unprecedented protection against the harmful effects of UVA radiation in sunlight, which include photo-ageing, cell damage and cancer.
Biotechnology and Biological Sciences Research Council

Contact: Chris Melvin
c.m.melvin@bath.ac.uk
44-012-253-83941
University of Bath

Public Release: 20-Jul-2016
eLife
Disturbances in blood cell gene transcription may lead to leukemia
Researchers have succeeded in shedding light on the pathogenesis of DNA breakpoints that are associated with leukemia. A mechanism discovered in a recent study can explain up to 90 percent of DNA damages present in the most common type of leukemia in children. The study was carried out by the University of Eastern Finland and the University of Tampere, and the findings were published in eLife.
Emil Aaltonen Foundation, Jane and Aatos Erkko Foundation, Finnish Cancer Foundation, Finnish Cultural Foundation, Finnish Paediatric Research Foundation, Academy of Finland, University of Eastern Finland, University of Tampere

Contact: Merja Heinäniemi
merja.heinaniemi@uef.fi
358-403-553-842
University of Eastern Finland

Public Release: 20-Jul-2016
Nature
Uncovering a new principle in chemotherapy resistance in breast cancer
A laboratory study has revealed an entirely unexpected process for acquiring drug resistance that bypasses the need to re-establish DNA damage repair in breast cancers that have mutant BRCA1 or BRCA2 genes.
NIH/National Cancer Institute

Contact: NCI Media Relations
ncipressofficers@mail.nih.gov
301-496-6641
NIH/National Cancer Institute

Public Release: 20-Jul-2016
The BMJ
Study raises concerns over unnecessary imaging after thyroid cancer
A marked rise in use of imaging tests after thyroid cancer has been associated with increased treatment for recurrence, but no clear improvement in survival from the disease, finds a study in The BMJ today.

Contact: Emma Dickinson
edickinson@bmj.com
44-207-383-6529
BMJ

Public Release: 20-Jul-2016
BMJ
Imaging after thyroid cancer treatment does not necessarily mean better outcomes
More imaging after thyroid cancer treatment identifies recurrence, but it does not always improve survival, a new study suggests.
NIH/National Cancer Institute, Punya Foundation for Thyroid Cancer Research

Contact: Nicole Fawcett
nfawcett@umich.edu
734-764-2220
University of Michigan Health System

Public Release: 20-Jul-2016
Scientific Reports
Liquid biopsies offer hope for earlier treatment, better tracking of ovarian cancer
Researchers at the Mayo Clinic Center for Individualized Medicine have found a promising new way to monitor and treat recurrence of ovarian cancer -- a hard-to-detect disease that claims many lives. New research from George Vasmatzis, Ph.D., of the Department of Laboratory Medicine and Pathology at Mayo Clinic, finds liquid biopsies from blood tests and DNA sequencing can detect a return of ovarian cancer long before a tumor reappears.

Contact: Susan Buckles
newsbureau@mayo.edu
507-284-5005
Mayo Clinic

Public Release: 20-Jul-2016
Nanomedicine: Nanotechnology, Biology, and Medicine
Nanoparticle versus cancer
The Lomonosov Moscow State University researchers in collaboration with their German colleagues have succeeded in proving that silicon nanoparticles can be applied to diagnose and cure cancer.

Contact: Vladimir Koryagin
science-release@rector.msu.ru
Lomonosov Moscow State University

Public Release: 20-Jul-2016
Gynecologic Oncology
Pap screenings linked to less cervical cancer in elderly women
A new study from the University of Illinois confirms a link between Pap smear screenings and a lower risk of developing cervical cancer in women over age 65. However, most American health guidelines discourage women in that age range from receiving screenings unless they have pre-existing risk factors.

Contact: Sarah Banducci
diya@illinois.edu
217-333-5802
University of Illinois at Urbana-Champaign

Public Release: 20-Jul-2016
Nature Communications
Case Western Reserve University researchers block common colon cancer tumor type in mice
A new scientific study has identified why colorectal cancer cells depend on a specific nutrient, and a way to starve them of it.
National Institutes of Health

Contact: Marc Kaplan
marc.kaplan@case.edu
216-368-4692
Case Western Reserve University

Public Release: 20-Jul-2016
The Lancet
Combining new and old drugs improves survival for soft-tissue cancer patients
Adding a novel monoclonal antibody therapy called olaratumab to traditional chemotherapy increased median survival by nearly a year in patients with advanced sarcoma, according to a multicenter clinical trial led by researchers at Columbia University Medical Center and NewYork-Presbyterian.
Eli Lilly and Company

Contact: Karin Eskenazi
ket2116@columbia.edu
212-342-0508
Columbia University Medical Center

Public Release: 20-Jul-2016
Cell Stem Cell
Cancer stem cells in 'robbers cave' may explain poor prognosis for obese patients
University of Colorado Cancer Center study published in the journal Cell Stem Cell offers a compelling hypothesis explaining poor prognosis for obese cancer patients: researchers found that leukemia stem cells "hide" in fatty tissue, even transforming this tissue in ways that support their survival when challenged with chemotherapy.
NIH/National Cancer Institute, National Institutes of Health

Contact: Garth Sundem
garth.sundem@ucdenver.edu
University of Colorado Anschutz Medical Campus

Public Release: 19-Jul-2016
Prostate Cancer and Prostatic Diseases
Prostate cancer: should screening test procedures be tightened again?
The number of new cases of men suffering from metastatic prostate cancer has risen significantly in a decade's time, and is 72 percent greater in the year 2013 compared to 2004. This is according to the authors Adam Weiner and Edward Schaeffer of Northwestern University Feinberg School of Medicine in the US. Their findings are published in Springer Nature's journal Prostate Cancer and Prostatic Diseases.
Prostate Cancer Foundation

Contact: Joan Robinson
joan.robinson@springer.com
49-622-148-78130
Springer

Public Release: 19-Jul-2016
Gut
Lower risk of bowel cancer death linked to high omega 3 intake after diagnosis
A high dietary intake of omega 3 fatty acids, derived from oily fish, may help to lower the risk of death from bowel cancer in patients diagnosed with the disease, suggests research published online in the journal Gut.

Contact: Caroline White
cwhite@bmj.com
44-798-080-0465
BMJ

Public Release: 19-Jul-2016
Journal of the American Academy of Dermatology
Many skin cancer patients still too likely to sunburn
A recent study by researchers at Johns Hopkins concludes that a substantial number of people with a history of the most frequent kind of nonmelanoma skin cancers still get sunburned at the same rate as those without previous history, probably because they are not using sun-protective methods the right way or in the right amounts.
Johns Hopkins Department of Dermatology, Johns Hopkins University School of Medicine, National Institutes of Health, and others

Contact: Taylor Graham
tgraha10@jhm.edu
443-287-8560
Johns Hopkins Medicine

Public Release: 19-Jul-2016
New England Journal of Medicine
New treatment developed to prevent nausea, vomiting caused by chemo
A drug that blocks neurotransmitters could reduce nausea and vomiting caused by chemotherapy, research co-authored by a Sanford Health physician and published in the New England Journal of Medicine finds.
NIH/National Cancer Institute

Contact: Tim Gerszewski
timothy.gerszewski@sanfordhealth.org
605-366-2432
Sanford Health/Sanford Research

Public Release: 19-Jul-2016
Cancer Research UK boosts efforts to overcome deadliest cancer as rates climb
CANCER RESEARCH UK has tripled its investment in pancreatic cancer, one of the hardest cancers to treat, since launching its research strategy in 2014 according to new figures published today (Wednesday).
Cancer Research UK

Contact: Emily Head
emily.head@cancer.org.uk
020-346-96189
Cancer Research UK

Showing releases 226-250 out of 1377.

<< < 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 > >>

  Search News Releases

     

 

EurekAlert!